FDA Inspection 1112416 — Mark Berman, M.D.

Mark Berman, M.D. — FEI 3010907482

The FDA completed an inspection of Mark Berman, M.D. on December 5, 2019 in Beverly Hills, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 15 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 5, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Beverly Hills, CA (United States)

Citations

IDCFRDescription
1471021 CFR 820.150Lack of or inadequate procedures for storage.
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation
63021 CFR 803.17Lack of Written MDR Procedures